Quick Answer: Key Differences Between Xeomin and Botox
Xeomin and Botox are both FDA-approved neurotoxins containing botulinum toxin type A that temporarily relax facial muscles to reduce wrinkles. The main difference is in their formulation: Xeomin is a "naked" neurotoxin containing only pure botulinum toxin type A (150 kDa) without any accessory proteins, while Botox contains the active neurotoxin plus complexing proteins.
Here's what you need to know about Xeomin vs Botox:
Formulation:
- Xeomin: Pure botulinum toxin A without accessory proteins
- Botox: Botulinum toxin A plus complexing proteins
Antibody resistance risk:
- Xeomin: Lower theoretical risk due to no accessory proteins
- Botox: Slightly higher protein load may increase antibody formation risk over time
Duration: Both last 3-4 months on average for cosmetic use. Individual results vary based on metabolism and treatment area.
Cost: Both typically priced at $10-$25 per unit. Xeomin may be slightly less expensive in some markets.
Onset: Both take 3-7 days to see initial results, 10-14 days for full effect. Some patients report Xeomin working slightly faster (anecdotal).
The two products are considered clinically equivalent at a 1:1 unit conversion ratio, meaning the same number of units produces similar results for most people.
Understanding Botulinum Toxin Products
Before comparing specific differences, it helps to understand what these products are and how they work.
How Neurotoxins Work
Both Xeomin and Botox contain botulinum toxin type A, derived from the bacterium Clostridium botulinum. When injected in small, controlled doses into specific facial muscles, the toxin temporarily blocks nerve signals that tell muscles to contract.
This muscle relaxation reduces the appearance of dynamic wrinkles (lines that form from repeated facial expressions like frowning, squinting, or raising your eyebrows). Over 3-4 months, the effects gradually wear off as your body metabolizes the toxin and nerve signals resume.
FDA Approvals
Botox received FDA approval for cosmetic use in 2002 for frown lines between the eyebrows, with subsequent approvals for crow's feet (2013) and forehead lines (2017). It's been on the market for over 20 years.
Xeomin received FDA approval in 2010, initially for medical conditions like cervical dystonia and blepharospasm. In 2011, it gained approval for cosmetic treatment of moderate to severe frown lines. Most recently, Xeomin became the first neurotoxin approved for simultaneous treatment of all three upper facial areas (forehead lines, frown lines, and crow's feet).
Both can be used off-label for other cosmetic applications beyond their specific FDA approvals, which is common practice.
The "Naked" Neurotoxin: What Makes Xeomin Different
The most significant distinction between these products lies in their molecular composition.
Protein Content Explained
Xeomin is often called a "naked" neurotoxin because it contains only the active 150 kDa botulinum toxin A molecule without any complexing proteins. The manufacturing process uses chromatographic purification to separate and remove all accessory proteins, leaving just the pure neurotoxin.
Botox contains the same active neurotoxin but also includes complexing proteins (hemagglutinins and non-hemagglutinins) that surround the toxin molecule, creating a larger molecular complex. These proteins occur naturally during the fermentation process.
Why This Difference Matters
The presence or absence of accessory proteins has a few potential implications:
Antibody formation risk: Your immune system can potentially develop neutralizing antibodies against the proteins in botulinum toxin products. Xeomin contains significantly less clostridial protein (approximately 0.6 ng per 100 units) compared to Botox (approximately 5 ng per 100 units). This lower "protein load" theoretically reduces the risk of antibody development.
Treatment resistance: If your body develops antibodies against the toxin or its accompanying proteins, treatments may become less effective or stop working entirely. This is relatively rare (occurring in less than 1-3% of patients), but it's more likely with products containing more protein.
Allergic reactions: People with sensitivities to the accessory proteins in Botox might tolerate Xeomin better, though allergic reactions to neurotoxins are uncommon overall.
Storage Requirements
Xeomin is the only neurotoxin that doesn't require refrigeration before reconstitution, remaining stable at room temperature for up to 3-4 years. Botox requires refrigerated storage. After reconstitution, both should be used within 24 hours and stored at 4°C (39°F).
This difference matters more for practices than patients, but it does simplify distribution and storage logistics.
Xeomin vs Botox Results and Effectiveness
The most important question is: do they work equally well?
Clinical Equivalence
Multiple clinical studies have demonstrated that Xeomin and Botox show comparable efficacy when used at the same dosage (1:1 unit conversion). Research published in peer-reviewed journals found Xeomin to be "non-inferior" to Botox in treating wrinkles and medical conditions.
In practical terms, this means:
- Same number of units needed for each treatment area
- Similar reduction in wrinkle appearance
- Comparable patient satisfaction rates
- Similar adverse event profiles
Results Timeline
Initial effects:
- Botox: Typically visible within 3-5 days
- Xeomin: Often visible within 2-3 days (though clinical data on this is mixed)
Full results: Both: Maximum effect at 10-14 days.
Duration: Both: 3-4 months average for cosmetic use. Some patients report Xeomin lasting slightly longer (up to 4-6 months), though this varies significantly by individual.
The anecdotal reports of faster onset or longer duration with Xeomin haven't been consistently demonstrated in head-to-head studies, so individual experiences vary.
Treatment Areas
Both Xeomin and Botox are used for the same cosmetic applications:
FDA-approved areas:
- Frown lines (glabellar lines) between the eyebrows
- Horizontal forehead lines
- Crow's feet around the eyes
Common off-label uses:
- Botox brow lift
- Lip flip
- Bunny lines on the nose
- Downturned corners of the mouth
- Chin dimpling (cobblestone chin)
- Neck bands (platysmal bands)
Unit requirements for each area are the same between the two products.
Xeomin vs Botox Cost Comparison
Pricing for neurotoxins can vary significantly based on location and provider.
Per-Unit Pricing
Both products typically cost:
- $10-$15 per unit: Smaller cities and competitive markets
- $12-$18 per unit: Mid-sized cities
- $15-$25 per unit: Major metropolitan areas like NYC, LA, San Francisco
Xeomin may be priced slightly lower ($1-3 per unit less) at some practices, but the difference isn't always significant. Some practices charge the same rate for both products.
Treatment Cost Examples
Since both use the same number of units for each area, your total cost depends primarily on the per-unit rate:
Frown lines (20 units):
- At $12/unit: $240
- At $18/unit: $360
Forehead + frown lines (40 units):
- At $12/unit: $480
- At $18/unit: $720
Full face treatment (64 units):
- At $12/unit: $768
- At $18/unit: $1,152
The cost of Botox or Xeomin for maintenance over a year (3-4 treatments) can range from $900-$4,000+ depending on your treatment areas and provider pricing.
Insurance Coverage
Neither Xeomin nor Botox is covered by insurance for cosmetic purposes. However, both have medical indications (like chronic migraines, excessive sweating, or TMJ treatment) that may qualify for insurance coverage with proper documentation and pre-authorization.
Side Effects and Safety Profile
Both products have similar safety profiles and potential side effects.
Common Side Effects
These occur with similar frequency for both Xeomin and Botox:
- Pain, bruising, or swelling at injection sites
- Temporary headache (usually resolves within 24-48 hours)
- Eyelid drooping (ptosis) if toxin migrates, typically resolves in 2-4 weeks
- Eyebrow drooping from improper placement or dosing
- Flu-like symptoms
Most side effects are mild and temporary, resolving within days to weeks.
Serious Risks
Both products carry the same boxed warning from the FDA regarding potential spread of toxin effects beyond the injection site. While rare, this can cause:
- Difficulty swallowing or breathing
- Muscle weakness
- Vision problems
These serious effects are more common when products are used off-label at high doses or administered improperly. When used for cosmetic purposes by trained providers, serious complications are extremely rare.
Allergic Reactions
Allergic reactions to botulinum toxin products are uncommon but possible. Some theoretical advantages of Xeomin's pure formulation include:
- Lower risk of reactions to accessory proteins (since there are none)
- Potentially better option for people who've had reactions to Botox
- Less likelihood of developing sensitivity with repeated treatments
However, true allergic reactions to the neurotoxin itself can still occur with either product. Symptoms might include hives, itching, shortness of breath, or swelling.
Who Should Choose Xeomin vs Botox
Neither product is universally "better," but certain situations might favor one over the other.
Consider Xeomin If:
You've developed treatment resistance: If Botox seems to work less effectively over time or doesn't last as long as it used to, you might have developed antibodies against the complexing proteins. Switching to Xeomin could restore effectiveness.
You want to minimize antibody risk: If you plan long-term, ongoing treatment over many years, Xeomin's lower protein load theoretically reduces the chance of developing resistance.
You've had reactions to Botox: People who experienced allergic symptoms with Botox might tolerate Xeomin better, though you should discuss this with your provider first.
Cost is a factor: If your provider offers Xeomin at a lower price point, it could provide savings without compromising results.
Consider Botox If:
You prefer the established brand: Botox has been on the market longer and has more extensive long-term safety data from over 20 years of use.
You have a positive history with it: If you've used Botox successfully and are happy with your results, there's no compelling reason to switch.
Your provider prefers it: Providers develop preferences based on their experience. If your trusted injector primarily uses Botox and is highly skilled with it, their expertise might outweigh any theoretical advantages of Xeomin.
Brand recognition matters to you: Some people prefer Botox simply because it's the most recognized name in neurotoxins.
When Either Works Equally Well
For most first-time patients with no history of reactions or resistance, either product will likely produce similar results. The choice often comes down to:
- Provider availability and preference
- Price difference at your chosen practice
- Personal preference or brand comfort
Switching Between Xeomin and Botox
If you've been using one product and want to try the other, here's what to know.
Unit Conversion
Xeomin and Botox use a 1:1 unit conversion, meaning if you typically get 20 units of Botox in your frown lines, you'd get 20 units of Xeomin for the same area. This makes switching straightforward compared to Dysport, which requires different dosing.
Not Interchangeable
Despite the 1:1 conversion, the FDA specifies that these products should not be used interchangeably, meaning you shouldn't receive both in the same treatment session or mix them in your treatment plan. Stick with one product consistently.
What to Expect When Switching
Some people notice subtle differences when switching:
- Slightly different onset timing
- Minor variations in how the product "feels" or spreads
- Possible changes in duration (longer or shorter)
These differences are usually minor, and most people find the results comparable. Give the new product 2-3 treatment cycles before deciding if you prefer it over your previous choice.
Other Neurotoxin Alternatives
Xeomin and Botox aren't your only options. Other neurotoxins available include:
Dysport
Like Botox, Dysport contains accessory proteins. It uses different unit dosing (typically 2.5-3:1 ratio compared to Botox) and may spread slightly more than other neurotoxins, which can be beneficial for larger treatment areas.
Jeuveau
Jeuveau (prabotulinumtoxinA-xvfs) is sometimes marketed as "Newtox" and is specifically FDA-approved only for cosmetic use. It contains accessory proteins and is dosed similarly to Botox.
Daxxify
The newest FDA-approved neurotoxin, Daxxify claims to last up to 6 months (twice as long as others) due to a peptide-stabilized formulation. It's more expensive per treatment but could be cost-effective if you need fewer sessions annually.
Each has its own characteristics, and your provider can help you understand which might work best for your specific needs and goals.
Questions to Ask Your Provider
When deciding between Xeomin and Botox, have a detailed conversation with your injector.
Important questions include:
- Which product do you use more frequently, and why?
- Do you see any differences in results between Xeomin and Botox?
- Is there a price difference between the two at your practice?
- Do you have experience treating patients who've switched between them?
- Based on my treatment history, which would you recommend?
- What happens if I'm not satisfied with my results?
- Do you offer a follow-up visit to assess results and make adjustments?
An experienced injector's preference and expertise with a particular product often matters more than minor theoretical differences between formulations.
Making Your Decision
Xeomin and Botox are both effective, FDA-approved neurotoxins for reducing facial wrinkles. They work similarly, last about the same amount of time, and produce comparable results for most patients.
The main difference is Xeomin's pure formulation without accessory proteins, which theoretically reduces the risk of antibody formation and allergic reactions. This makes it potentially advantageous for long-term use or for people who've developed resistance to Botox.
For most first-time patients, either product will work well. Your choice might come down to provider preference, pricing, or brand recognition. If you've been using Botox successfully, there's no compelling reason to switch. If you've experienced diminishing results or reactions with Botox, Xeomin could be worth trying.
The most important factor isn't which product you choose, but rather finding an experienced, qualified injector who understands facial anatomy and can deliver natural-looking results with whichever neurotoxin they're using.